Testing Laboratories - Insider Trading Data
Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Testing industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.
Testing Laboratories - Insider Buy/Sell Ratio
Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.
We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).
Testing Laboratories - Transaction History
Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.
| Tran Date |
Security | Form | Insider | Code | Direct | Share Price |
Shares Changed |
|
|---|---|---|---|---|---|---|---|---|
| 2020-11-24 | NEO / NeoGenomics, Inc. | 4 | CARDOZA GEORGE | D | 7.52 | 72,926 | ||
| 2020-11-24 | NEO / NeoGenomics, Inc. | 4 | CARDOZA GEORGE | D | 45.19 | -52,926 | ||
| 2020-11-16 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | 7.52 | 20,000 | ||
| 2020-11-16 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | -20,000 | |||
| 2020-11-16 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | 42.34 | -100,000 | ||
| 2020-11-16 | NEO / NeoGenomics, Inc. | 4 | HIPP RAYMOND R | D | 42.28 | -70,000 | ||
| 2020-11-13 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | -358,752 | |||
| 2020-11-13 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | 7.52 | 358,752 | ||
| 2020-11-13 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | 41.56 | -118,752 | ||
| 2020-11-12 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | 7.52 | 121,248 | ||
| 2020-11-12 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | -121,248 | |||
| 2020-11-12 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | 42.18 | -121,248 | ||
| 2020-11-10 | NEO / NeoGenomics, Inc. | 4 | Pedulla Denise E | D | 7.85 | 15,000 | ||
| 2020-11-10 | NEO / NeoGenomics, Inc. | 4 | Pedulla Denise E | D | -15,000 | |||
| 2020-11-10 | NEO / NeoGenomics, Inc. | 4 | Pedulla Denise E | D | 42 | -2,262 | ||
| 2020-10-19 | APDN / Applied DNA Sciences, Inc. | 4 | Anchin Scott L | D | 18,465 | |||
| 2020-10-19 | APDN / Applied DNA Sciences, Inc. | 4 | Anchin Scott L | D | 5,573 | |||
| 2020-10-19 | APDN / Applied DNA Sciences, Inc. | 4 | Murrah Judith | D | 13,035 | |||
| 2020-10-19 | APDN / Applied DNA Sciences, Inc. | 4 | Jantzen Beth | D | 13,035 | |||
| 2020-10-19 | APDN / Applied DNA Sciences, Inc. | 4 | Hayward James A | D | 13,035 | |||
| 2020-09-29 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C | D | -25,000 | |||
| 2020-09-29 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 36.95 | -141,049 | ||
| 2020-09-29 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C | D | 36.55 | -81,000 | ||
| 2020-09-28 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 36.34 | -38,951 | ||
| 2020-09-28 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C | D | 36.56 | -19,000 | ||
| 2020-09-25 | DIGP / Hypha Labs, Inc. | 4 | Peterson Todd A | D | 657,895 | |||
| 2020-09-24 | NEO / NeoGenomics, Inc. | 4 | CROWTHER BRUCE K | D | -8,333 | |||
| 2020-09-24 | NEO / NeoGenomics, Inc. | 4 | CROWTHER BRUCE K | D | 9.11 | 8,333 | ||
| 2020-09-24 | NEO / NeoGenomics, Inc. | 4 | CROWTHER BRUCE K | D | 35.01 | -8,333 | ||
| 2020-09-22 | NEO / NeoGenomics, Inc. | 4 | CROWTHER BRUCE K | D | 35.68 | -2,400 | ||
| 2020-09-10 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 37.13 | -37,991 | ||
| 2020-09-09 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 36.98 | -71,583 | ||
| 2020-09-08 | NEO / NeoGenomics, Inc. | 4 | JONES STEVEN C By Aspen Select Opportunity Fund | I | 36.13 | -10,426 | ||
| 2020-08-12 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | -10,000 | |||
| 2020-08-11 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | -10,000 | |||
| 2020-08-11 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M Custodial Account for Child | I | 5,000 | |||
| 2020-08-11 | NEO / NeoGenomics, Inc. | 4 | VAN OORT DOUGLAS M | D | -5,000 | |||
| 2020-08-06 | NEO / NeoGenomics, Inc. | 4 | CARDOZA GEORGE | D | -100,000 | |||
| 2020-08-06 | NEO / NeoGenomics, Inc. | 4 | CARDOZA GEORGE | D | 7.15 | 100,000 | ||
| 2020-08-06 | NEO / NeoGenomics, Inc. | 4 | HANNAH ALISON L. | D | -10,000 | |||
| 2020-08-06 | NEO / NeoGenomics, Inc. | 4 | HANNAH ALISON L. | D | 7.27 | 10,000 | ||
| 2020-08-06 | NEO / NeoGenomics, Inc. | 4 | CARDOZA GEORGE | D | 39.35 | -82,500 | ||
| 2020-08-03 | NEO / NeoGenomics, Inc. | 4 | BALLIET JENNIFER | D | 7.52 | 13,000 | ||
| 2020-08-03 | NEO / NeoGenomics, Inc. | 4 | BALLIET JENNIFER | D | -13,000 | |||
| 2020-08-03 | NEO / NeoGenomics, Inc. | 4 | Bonello William | D | -1,964 | |||
| 2020-08-03 | NEO / NeoGenomics, Inc. | 4 | Bonello William | D | 7.52 | 20,036 | ||
| 2020-08-03 | NEO / NeoGenomics, Inc. | 4 | Bonello William | D | 8.03 | 1,964 | ||
| 2020-08-03 | NEO / NeoGenomics, Inc. | 4 | Bonello William | D | -20,036 | |||
| 2020-08-03 | NEO / NeoGenomics, Inc. | 4 | BALLIET JENNIFER | D | 39.25 | -13,000 | ||
| 2020-08-03 | NEO / NeoGenomics, Inc. | 4 | Bonello William | D | 38.61 | -22,000 |
